693 related articles for article (PubMed ID: 19076631)
1. Differences in nitrate reduction between Mycobacterium tuberculosis and Mycobacterium bovis are due to differential expression of both narGHJI and narK2.
Sohaskey CD; Modesti L
FEMS Microbiol Lett; 2009 Jan; 290(2):129-34. PubMed ID: 19076631
[TBL] [Abstract][Full Text] [Related]
2. A single-nucleotide mutation in the -10 promoter region inactivates the narK2X promoter in Mycobacterium bovis and Mycobacterium bovis BCG and has an application in diagnosis.
Chauhan S; Singh A; Tyagi JS
FEMS Microbiol Lett; 2010 Feb; 303(2):190-6. PubMed ID: 20041953
[TBL] [Abstract][Full Text] [Related]
3. Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis.
Sohaskey CD; Wayne LG
J Bacteriol; 2003 Dec; 185(24):7247-56. PubMed ID: 14645286
[TBL] [Abstract][Full Text] [Related]
4. Simple and rapid method for detection of nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium canettii grown in the Bactec MGIT960 system.
Goh KS; Rastogi N
J Microbiol Methods; 2010 May; 81(2):208-10. PubMed ID: 20298726
[TBL] [Abstract][Full Text] [Related]
5. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice.
Weber I; Fritz C; Ruttkowski S; Kreft A; Bange FC
Mol Microbiol; 2000 Mar; 35(5):1017-25. PubMed ID: 10712684
[TBL] [Abstract][Full Text] [Related]
6. Anaerobic growth of Corynebacterium glutamicum using nitrate as a terminal electron acceptor.
Nishimura T; Vertès AA; Shinoda Y; Inui M; Yukawa H
Appl Microbiol Biotechnol; 2007 Jun; 75(4):889-97. PubMed ID: 17347820
[TBL] [Abstract][Full Text] [Related]
7. Phylogenomics of Mycobacterium Nitrate Reductase Operon.
Huang Q; Abdalla AE; Xie J
Curr Microbiol; 2015 Jul; 71(1):121-8. PubMed ID: 25980349
[TBL] [Abstract][Full Text] [Related]
8. A promoter mutation causes differential nitrate reductase activity of Mycobacterium tuberculosis and Mycobacterium bovis.
Stermann M; Sedlacek L; Maass S; Bange FC
J Bacteriol; 2004 May; 186(9):2856-61. PubMed ID: 15090527
[TBL] [Abstract][Full Text] [Related]
9. Molecular evolutionary history of tubercle bacilli assessed by study of the polymorphic nucleotide within the nitrate reductase (narGHJI) operon promoter.
Goh KS; Rastogi N; Berchel M; Huard RC; Sola C
J Clin Microbiol; 2005 Aug; 43(8):4010-4. PubMed ID: 16081943
[TBL] [Abstract][Full Text] [Related]
10. The roles of the nitrate reductase NarGHJI, the nitrite reductase NirBD and the response regulator GlnR in nitrate assimilation of Mycobacterium tuberculosis.
Malm S; Tiffert Y; Micklinghoff J; Schultze S; Joost I; Weber I; Horst S; Ackermann B; Schmidt M; Wohlleben W; Ehlers S; Geffers R; Reuther J; Bange FC
Microbiology (Reading); 2009 Apr; 155(Pt 4):1332-1339. PubMed ID: 19332834
[TBL] [Abstract][Full Text] [Related]
11. Independent transcription of glutamine synthetase (glnA2) and glutamine synthetase adenylyltransferase (glnE) in Mycobacterium bovis and Mycobacterium tuberculosis.
Hotter GS; Mouat P; Collins DM
Tuberculosis (Edinb); 2008 Sep; 88(5):382-9. PubMed ID: 18440867
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium bovis BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy.
Honaker RW; Stewart A; Schittone S; Izzo A; Klein MR; Voskuil MI
Infect Immun; 2008 Jun; 76(6):2587-93. PubMed ID: 18362135
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis.
Stermann M; Bohrssen A; Diephaus C; Maass S; Bange FC
J Clin Microbiol; 2003 Jul; 41(7):3252-9. PubMed ID: 12843072
[TBL] [Abstract][Full Text] [Related]
15. Crystalline nitrate reductase reagent for drug susceptibility testing of Mycobacterium tuberculosis.
Panaiotov S
Int J Antimicrob Agents; 2009 Aug; 34(2):191-2. PubMed ID: 19346106
[No Abstract] [Full Text] [Related]
16. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
DasGupta SK; Jain S; Kaushal D; Tyagi AK
Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the respiratory nitrate transporter NarK2 of Mycobacterium tuberculosis.
Giffin MM; Raab RW; Morganstern M; Sohaskey CD
PLoS One; 2012; 7(9):e45459. PubMed ID: 23029022
[TBL] [Abstract][Full Text] [Related]
18. 'Proteomic contigs' of Mycobacterium tuberculosis and Mycobacterium bovis (BCG) using novel immobilised pH gradients.
Urquhart BL; Atsalos TE; Roach D; Basseal DJ; Bjellqvist B; Britton WL; Humphery-Smith I
Electrophoresis; 1997 Aug; 18(8):1384-92. PubMed ID: 9298652
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
[TBL] [Abstract][Full Text] [Related]
20. Development of infection model for studying intracellular gene expression of Mycobacterium tuberculosis.
Alli OA; Ogbolu DO; Spreadbury CL
Afr J Med Med Sci; 2009 Dec; 38(4):325-32. PubMed ID: 20499625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
